CIK 0001875558
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Nuvectis Pharma, Inc.
Sign in to watch- Ticker
- NVCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 862405608
- Phone
- +1 360-837-7232
- Business address
- 1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, 07024
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Open-market buy 10% owner bought 21,167 shares at $8.11 ($171,664)
- 4/A Open-market buy 10% owner bought 27,662 shares at an average $8.94 ($247,263)
- 4 Open-market buy 10% owner bought 27,411 shares at an average $8.60 ($235,647)
- 4 Open-market buy 10% owner bought 240,000 shares at $5.00 ($1,200,000)
- 4 Grant or award Chief Dev. & Ops. Officer acquired 150,000 shares (grant or award)
- 4 Grant or award Chief Science & Business Off acquired 150,000 shares (grant or award)
- 4 Grant or award Vice President, Finance acquired 51,000 shares (grant or award)
- 4 Grant or award Chairman & CEO acquired 250,000 shares (grant or award)
- 4 Open-market buy Chairman & CEO bought 4,500 shares at $4.65 ($20,925)
- 4/A Open-market buy 10% owner bought 49,121 shares at an average $4.66 ($228,941)
- 4 Open-market buy 10% owner bought 17,000 shares at $4.70 ($79,900)
- 4 Open-market buy Chief Science & Business Off bought 2,000 shares at $4.99 ($9,980)
- 4 Open-market buy Chairman & CEO bought 20,000 shares at $4.92 ($98,400)
- 4 Open-market sale Vice President, Finance sold 2,755 shares at $8.16 ($22,478)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Open-market buy Chairman & CEO bought 1,940 shares at $6.74 ($13,076)
Page 2 of 7 · 139 filings